Carregant...

CDK4/6 inhibitors: a novel strategy for tumor radiosensitization

Recently, the focus of enhancing tumor radiosensitivity has shifted from chemotherapeutics to targeted therapies. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are a novel class of selective cell cycle therapeutics that target the cyclin D-CDK4/6 complex and induce G1 phase arrest. These agent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Yang, Yilan, Luo, Jurui, Chen, Xingxing, Yang, Zhaozhi, Mei, Xin, Ma, Jinli, Zhang, Zhen, Guo, Xiaomao, Yu, Xiaoli
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490904/
https://ncbi.nlm.nih.gov/pubmed/32933570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01693-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!